Helicobacter pylori-related gastroenterology studies

Helicobacter pylori, a bacterium that colonizes the stomach lining, is the leading infectious cause of gastric cancer, driving a cascade of chronic inflammation that can progress over decades from gastritis to malignancy. Researchers study how the bacterium's virulence factors interact with host genetics — including polymorphisms in interleukin-1 that amplify inflammatory responses — to determine why some infections advance to cancer while others do not. A pressing concern is the rising rate of antibiotic resistance, which threatens the effectiveness of standard eradication regimens and complicates efforts to reduce cancer incidence through treatment. Active work centers on identifying which patient populations benefit most from eradication therapy, refining surgical approaches for established disease, and developing resistance-aware treatment protocols.

Works

156,831

Total citations

2,224,077

Keywords

Gastric CancerHelicobacter pyloriInflammationAntibiotic ResistanceEradication TherapyPathogenesis